East China’s Jiangsu province is making every effort to create a market-oriented, legalized, and international first-class business environment so as to continuously stimulate the vitality of market entities in the improvement of government services.
Reindeer Medical Import Co., Ltd. is engaged in the research and development, technical service and clinical application of immune cell therapy technology.
At the centralized inspection and supervision point of the entry and exit special items in the Nanjing sub-zone of the Jiangsu Pilot Free Trade Zone, the company's cell products were released through the follow-up supervision by Jinling Customs.
"In the past we had to declare and queue up and wait for the customs to come to the door for inspection. Now, thanks to the centralized inspection platform, after the inspection is done on the same day, the goods will be released on the same day and the import and export efficiency has been greatly improved," said Cong Zhengyu, Senior Vice President of Nanjing Reindeer Medical Technology Co., Ltd.
Imported biological reagents are the basic materials for the research and development of the biopharmaceutical industry. The faster the inspection and delivery, the lower the activity damage rate of biological products.
In order to better facilitate customs clearance, the Nanjing Sub-zone of Jiangsu Pilot Free Trade Zone and Jinling Customs have jointly built a biomedical centralized supervision and public service platform, and constantly adjusted and improved the functions of the platform according to the enterprises’ actual demands.
"Due to the decentralization of approval authority, Jinling Customs has realized low-risk entry and exit biopharmaceutical approval customs declaration and inspection rapid inspection 'one-stop' inspection integration, so as to have shortened the inspection period from three days to one day," said Wang Dalong, Deputy Director of Jinling Customs Office in Jiangbei.
"We will focus on the requirements put forward by the province's business environment work promotion conference and the platform will continue to create a 'one-stop' service integrating clinical resources and health and medical data transformation, technology research and development innovation, regulatory services, and customs clearance facilitation to help the sub-zone significantly enhance the comprehensive competitiveness and collaborative innovation capabilities of the industry," said Zhu Hengwen, Director of the Scientific Service Department and Director of the Comprehensive Service Department of the Biopharmaceutical Public Service Platform in Jiangbei New District, Nanjing.
Xuzhou Economic and Technological Development Zone has explored the working mechanism jointly established by the Investment Promotion Bureau and its subordinate sub-district offices to improve the communication channels between government and enterprises.
Wuxi High-tech Zone launched "Biaoyi Loan" for small and medium-sized construction projects, allowing more financial living water to drip accurately to market players.
Yangzhou optimizes corporate credit restoration to accommodate prudential supervision and improve the convenience of credit assistance to enterprises.
"We used to take a week for credit repair, now we have shortened the process to the same day and we can repair the credit," said Zhi Hui, Deputy Director of the Credit and Risk Supervision Bureau of Yangzhou Market Supervision Bureau.
"'Biaoyidai' is an online application for automatic approval online self-service withdrawal and repayment and the approval time is short. Enterprises can apply for Biaoyi Loan by virtue of the bid winning notice and purchase contract," said Ma Xichun, staff member of the Administrative Examination and Approval Bureau of Wuxi High-tech Zone.
